Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04069429 · ClinicalTrials.gov registry record · Early Phase 1

Radiation Dose in Humans From Orally Administered Tc99m-Heparin

A Early Phase 1 study of Eosinophilic Esophagitis, sponsored by University of Utah.

Completed
Registry status
Early Phase 1
Development phase
8
Enrollment target
1
Study location

NCT04069429 is a Early Phase 1 study of Eosinophilic Esophagitis that has completed, run by University of Utah. The registered enrollment target is 8 participants, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04069429, a Early Phase 1 study of Eosinophilic Esophagitis, has completed, sponsored by University of Utah.

COMPLETED
Registry status
Early Phase 1
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

This is a research study of a new agent used for evaluation of inflammation in the GI tract. This agent is investigational and thus is being studied to determine appropriate dosing and administration in both normal controls (i.e. people without gastrointestinal complaints) and patients with eosinophilic disease (i.e. those with an immune reaction and inflammation in their bodies with a certain cell called an eosinophil). The study will test whether the radiolabeled agent will bind to the inflammation of eosinophilic esophagitis patients because an animal model of eosinophilic esophagitis which shows the striking deposition of eosinophil granule proteins is not available.

Conditions Studied

Eosinophilic Esophagitis

Interventions

  • PROCEDURE Esophagogastroduodenoscopy
  • RADIATION Computerized Tomography scan
  • RADIATION Single Photon Emission Computed Tomography scans
  • DRUG Technetium Tc 99M
  • RADIATION Planar Images

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2016-07
Est. Completion 2020-10
Phase Early Phase 1

Sponsor

University of Utah

818 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04069429

The ClinicalTrials.gov registry entry for NCT04069429 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (99% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 5 interventions - of which Esophagogastroduodenoscopy is the first listed.

NCT04069429 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT04069429 about?

NCT04069429 is a clinical study titled "Radiation Dose in Humans From Orally Administered Tc99m-Heparin". This is a research study of a new agent used for evaluation of inflammation in the GI tract. This agent is investigational and thus is being studied to determine appropriate dosing and administration in both normal controls (i.e. people without gastrointestinal complaints) and patients with eosinoph...

What is the current status of trial NCT04069429?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2016-07. Estimated completion is 2020-10.

What conditions does trial NCT04069429 study?

This clinical trial studies the following conditions: Eosinophilic Esophagitis.

What interventions are being tested in trial NCT04069429?

The interventions under investigation include: Esophagogastroduodenoscopy (PROCEDURE), Computerized Tomography scan (RADIATION), Single Photon Emission Computed Tomography scans (RADIATION), Technetium Tc 99M (DRUG), Planar Images (RADIATION).

Who is sponsoring clinical trial NCT04069429?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04069429 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Eosinophilic Esophagitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Eosinophilic Esophagitis

All registered trials for this condition

Utah

All trials with a study site in Utah

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.